A Prospective, Double Blind, Controlled Study Evaluating Safety and Preliminary Efficacy of a Single Injection of Adult Mesenchymal Precursor Cells (MPCs) Combined With Hyaluronan in Subjects With Chronic Discogenic Lumbar Back Pain
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Rexlemestrocel-L (Primary) ; Hyaluronic acid
- Indications Back pain; Intervertebral disc degeneration
- Focus Adverse reactions
- Sponsors Mesoblast
- 12 Oct 2016 Status changed from active, no longer recruiting to completed.
- 01 Aug 2016 Results of 24 months published in Mesoblast Limited media release.
- 01 Aug 2016 24 month results presented at the 24th Annual Scientific Meeting of the Spine Intervention Society (SIS), as per Mesoblast Limited media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History